Figure 1.

Flow of participants through the trial. TVC, total vaccinated cohort (all vaccinated subjects for whom data were available); TVC-E, total vaccinated cohort for efficacy (all vaccinated women for whom efficacy data were available and who had normal or low-grade cytology at baseline); ATP-E, according to protocol cohort for efficacy (all evaluable women who met eligibility criteria and complied with protocol procedures who received three doses of vaccine or control and had normal or low-grade cytology at baseline). *n*: number present in one group only and duplicated to avoid unblinding of ongoing study. ¹Completion status at Month 24 was unknown for these subjects at the time of this event-triggered analysis. ²ASC-H, HSIL, AGC or malignancy. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]